Results 231 to 240 of about 672,015 (400)

Comorbidities in People With Intellectual Disability With and Without Schizophrenia and Schizophrenia Without Intellectual Disability: A Swedish Register Study (IDcare)

open access: yesJournal of Intellectual Disability Research, Volume 70, Issue 2, Page 206-217, February 2026.
ABSTRACT Background Intellectual disability (ID) and schizophrenia are known to separately carry a high risk of comorbidity of mental health and physical conditions. However, the prevalence and risk of comorbidities among people diagnosed with concurrent ID and schizophrenia have to date not been studied.
Trine Lise Bakken   +2 more
wiley   +1 more source

Risk stratification of acute exacerbations by autoantibodies in patients with idiopathic interstitial pneumonia. [PDF]

open access: yesSci Rep
Yazawa S   +33 more
europepmc   +1 more source

An Example of Interstitial Pneumonia Developed during Treatment of Anti-MOG Antibody Positive Optic Neuritis

open access: diamond, 2023
Kazuki Yamada   +7 more
openalex   +2 more sources

Cryoglobulinemia: An update on classification, pathophysiology, clinical presentation, and management

open access: yesJournal of Internal Medicine, Volume 299, Issue 2, Page 196-215, February 2026.
Abstract Cryoglobulinemia (CG) is defined by the presence of serum immunoglobulins that precipitate below 37°C and redissolve upon rewarming. It is classified into three types based on immunoglobulin composition. Type I, a rare form, involves monoclonal IgM or IgG and is linked to lymphoproliferative disorders.
Anna Linda Zignego   +7 more
wiley   +1 more source

Variable Prostaglandin E 2 Resistance in Fibroblasts from Patients with Usual Interstitial Pneumonia

open access: green, 2007
Steven K. Huang   +9 more
openalex   +1 more source

Janus kinase and calcineurin‐inhibitor combination in anti‐MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile

open access: yesJournal of Internal Medicine, Volume 299, Issue 2, Page 228-240, February 2026.
Abstract Objectives Anti‐MDA5 dermatomyositis (anti‐MDA5 DM) is the most severe subtype of dermatomyositis, due to its pulmonary involvement. Current treatment involves corticosteroids and immunosuppressants, but variability in responses exists. This study aims to evaluate the efficacy and safety of Janus kinase (JAK)– and calcineurin–inhibitor ...
Valentine Pagis   +47 more
wiley   +1 more source

Interstitial pneumonia via the oropharyngeal route of infection with Encephalitozoon cuniculi. [PDF]

open access: yesPLoS Negl Trop Dis
Santos MS   +9 more
europepmc   +1 more source

Elevated serum and BAL cytokeratin 19 fragment in pulmonary fibrosis and acute interstitial pneumonia [PDF]

open access: bronze, 1999
N. Dobashi   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy